# B3GALT6

## Overview
The B3GALT6 gene encodes the enzyme beta-1,3-galactosyltransferase 6 (β3GalT6), a type II transmembrane protein that plays a pivotal role in the biosynthesis of glycosaminoglycans (GAGs), such as dermatan sulfate and chondroitin sulfate. This enzyme is integral to the formation of the tetrasaccharide linkage region that connects GAG chains to core proteins of proteoglycans, which are crucial components of the extracellular matrix (Delbaere2020b3galt6). The B3GALT6 protein is characterized by a GT-A fold, essential for its catalytic activity, and is active in the Golgi apparatus, where it facilitates the proper assembly and function of GAG chains (Delbaere2020b3galt6; Patel2007Foldrecognition). Mutations in the B3GALT6 gene are associated with severe connective tissue disorders, highlighting its critical role in maintaining tissue integrity and function (Caraffi2019Severe; Van2018Biallelic).

## Structure
The B3GALT6 protein, also known as beta-1,3-galactosyltransferase 6, is a type II transmembrane protein involved in glycosaminoglycan biosynthesis. It consists of a cytosolic domain (amino acids 1-11), a transmembrane domain (amino acids 12-34), and a luminal domain, which is highly conserved between humans and zebrafish, displaying 82.5% amino acid similarity (Delbaere2020b3galt6). The protein is characterized by the GT-A fold, which includes a Rossmann-fold-like αβα-sandwich and a motif comprising one β-strand and two α-helices. These motifs are crucial for substrate binding and catalytic activity (Patel2007Foldrecognition).

The B3GALT6 enzyme is responsible for transferring galactose to the Gal(α1-4)Xyl acceptor, completing the formation of the glycosaminoglycan core of proteoglycans (Hennet2002The). The protein's structure includes conserved sequence motifs, such as the DxD motif, which is essential for binding phosphate groups and metal ions, and a conserved aspartic acid residue critical for catalytic activity (Patel2007Foldrecognition). The primary structure of B3GALT6 has been analyzed, but specific details on its tertiary and quaternary structures are not provided in the available context.

## Function
The B3GALT6 gene encodes the enzyme beta-1,3-galactosyltransferase 6 (β3GalT6), which plays a crucial role in the biosynthesis of glycosaminoglycans (GAGs) such as dermatan sulfate and chondroitin sulfate. This enzyme is responsible for adding a galactose residue to the growing GAG chain, a critical step in the formation of the tetrasaccharide linkage region that connects GAG chains to the core proteins of proteoglycans (Delbaere2020b3galt6). Proteoglycans are essential components of the extracellular matrix and are involved in maintaining the structural integrity of tissues, influencing processes such as collagen fibril organization and muscle fiber function (Delbaere2020b3galt6).

In healthy human cells, β3GalT6 is active in the Golgi apparatus, where it facilitates the proper assembly and function of GAG chains. These chains undergo further modifications, such as epimerization and sulfation, which are essential for their diverse biological functions (Delbaere2020b3galt6). The enzyme's activity is vital for the development and maintenance of connective tissues, impacting skeletal development, joint function, and skin integrity (Delbaere2020b3galt6; Ritelli2015Insights). Deficiencies in this enzyme can lead to severe genetic disorders known as linkeropathies, characterized by skeletal dysplasia and other connective tissue abnormalities (Delbaere2020b3galt6).

## Clinical Significance
Mutations in the B3GALT6 gene are linked to several connective tissue disorders, most notably spondylodysplastic Ehlers-Danlos syndrome (spEDS) and spondyloepimetaphyseal dysplasia with joint hypermobility (SEMDJL1 or SEMDJL Beighton type). These conditions are characterized by skeletal abnormalities, joint hypermobility, and skin issues (Caraffi2019Severe; Van2018Biallelic). Biallelic mutations in B3GALT6 lead to a reduction in β3GalT6 protein levels and a complete loss of galactosyltransferase activity, resulting in deficient glycosaminoglycan (GAG) synthesis and abnormalities in collagen fibril organization (Malfait2013Defective; Van2018Biallelic).

Patients with B3GALT6 mutations may experience severe complications such as aortic dilatation, aneurysms, cervical spine instability, and respiratory insufficiency (Caraffi2019Severe; Van2018Biallelic). The mutations can also lead to a severe progeroid form of Ehlers-Danlos syndrome (EDSSPD2) and Al-Gazali syndrome, which includes prenatal growth retardation, skeletal anomalies, and early lethality (Leoni2021Broadening). A novel dominant variant of B3GALT6 has been identified, which causes moderate malformations, expanding the understanding of the gene's role in human pathology (Shen2022Mutant).


## References


[1. (Ritelli2015Insights) Marco Ritelli, Nicola Chiarelli, Nicoletta Zoppi, Chiara Dordoni, Stefano Quinzani, Michele Traversa, Marina Venturini, Piergiacomo Calzavara-Pinton, and Marina Colombi. Insights in the etiopathology of galactosyltransferase ii (galt-ii) deficiency from transcriptome-wide expression profiling of skin fibroblasts of two sisters with compound heterozygosity for two novel b3galt6 mutations. Molecular Genetics and Metabolism Reports, 2:1–15, March 2015. URL: http://dx.doi.org/10.1016/j.ymgmr.2014.11.005, doi:10.1016/j.ymgmr.2014.11.005. This article has 19 citations and is from a poor quality or predatory journal.](https://doi.org/10.1016/j.ymgmr.2014.11.005)

[2. (Patel2007Foldrecognition) Ronak Y. Patel and Petety V. Balaji. Fold-recognition and comparative modeling of human β3galt i, ii, iv, v and vi and β3galnact i: prediction of residues conferring acceptor substrate specificity. Journal of Molecular Graphics and Modelling, 26(1):255–268, July 2007. URL: http://dx.doi.org/10.1016/j.jmgm.2006.12.003, doi:10.1016/j.jmgm.2006.12.003. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.jmgm.2006.12.003)

[3. (Malfait2013Defective) Fransiska Malfait, Ariana Kariminejad, Tim Van Damme, Caroline Gauche, Delfien Syx, Faten Merhi-Soussi, Sandrine Gulberti, Sofie Symoens, Suzanne Vanhauwaert, Andy Willaert, Bita Bozorgmehr, Mohamad Hasan Kariminejad, Nazanin Ebrahimiadib, Ingrid Hausser, Ann Huysseune, Sylvie Fournel-Gigleux, and Anne De Paepe. Defective initiation of glycosaminoglycan synthesis due to b3galt6 mutations causes a pleiotropic ehlers-danlos-syndrome-like connective tissue disorder. The American Journal of Human Genetics, 92(6):935–945, June 2013. URL: http://dx.doi.org/10.1016/j.ajhg.2013.04.016, doi:10.1016/j.ajhg.2013.04.016. This article has 110 citations.](https://doi.org/10.1016/j.ajhg.2013.04.016)

[4. (Van2018Biallelic) Tim Van Damme, Xiaomeng Pang, Brecht Guillemyn, Sandrine Gulberti, Delfien Syx, Riet De Rycke, Olivier Kaye, Christine E M de Die-Smulders, Rolph Pfundt, Ariana Kariminejad, Sheela Nampoothiri, Geneviève Pierquin, Saskia Bulk, Austin A Larson, Kathryn C Chatfield, Marleen Simon, Anne Legrand, Marion Gerard, Sofie Symoens, Sylvie Fournel-Gigleux, and Fransiska Malfait. Biallelic b3galt6 mutations cause spondylodysplastic ehlers–danlos syndrome. Human Molecular Genetics, 27(20):3475–3487, June 2018. URL: http://dx.doi.org/10.1093/hmg/ddy234, doi:10.1093/hmg/ddy234. This article has 32 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddy234)

[5. (Delbaere2020b3galt6) Sarah Delbaere, Adelbert De Clercq, Shuji Mizumoto, Fredrik Noborn, Jan Willem Bek, Lien Alluyn, Charlotte Gistelinck, Delfien Syx, Phil L. Salmon, Paul J. Coucke, Göran Larson, Shuhei Yamada, Andy Willaert, and Fransiska Malfait. B3galt6 knock-out zebrafish recapitulate β3galt6-deficiency disorders in human and reveal a trisaccharide proteoglycan linkage region. Frontiers in Cell and Developmental Biology, December 2020. URL: http://dx.doi.org/10.3389/fcell.2020.597857, doi:10.3389/fcell.2020.597857. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2020.597857)

[6. (Shen2022Mutant) Fang Shen, Yongjia Yang, Yu Zheng, Ming Tu, Liu Zhao, Zhenqing Luo, Yuyan Fu, and Yimin Zhu. Mutant b3galt6 in a multiplex family: a dominant variant co-segregated with moderate malformations. Frontiers in Genetics, June 2022. URL: http://dx.doi.org/10.3389/fgene.2022.824445, doi:10.3389/fgene.2022.824445. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2022.824445)

[7. (Caraffi2019Severe) Stefano Giuseppe Caraffi, Ilenia Maini, Ivan Ivanovski, Marzia Pollazzon, Sara Giangiobbe, Maurizia Valli, Antonio Rossi, Silvia Sassi, Silvia Faccioli, Maja Di Rocco, Cinzia Magnani, Belinda Campos-Xavier, Sheila Unger, Andrea Superti-Furga, and Livia Garavelli. Severe peripheral joint laxity is a distinctive clinical feature of spondylodysplastic-ehlers-danlos syndrome (eds)-b4galt7 and spondylodysplastic-eds-b3galt6. Genes, 10(10):799, October 2019. URL: http://dx.doi.org/10.3390/genes10100799, doi:10.3390/genes10100799. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes10100799)

[8. (Hennet2002The) T. Hennet. The galactosyltransferase family. Cellular and Molecular Life Sciences (CMLS), 59(7):1081–1095, July 2002. URL: http://dx.doi.org/10.1007/s00018-002-8489-4, doi:10.1007/s00018-002-8489-4. This article has 157 citations.](https://doi.org/10.1007/s00018-002-8489-4)

[9. (Leoni2021Broadening) Chiara Leoni, Marta Tedesco, Francesca Clementina Radio, Giovanni Chillemi, Antonio Leone, Alessandro Bruselles, Andrea Ciolfi, Emilia Stellacci, Francesca Pantaleoni, Gianfranco Butera, Donato Rigante, Roberta Onesimo, Marco Tartaglia, and Giuseppe Zampino. Broadening the phenotypic spectrum of <scp>beta3galt6</scp>‐associated phenotypes. American Journal of Medical Genetics Part A, 185(10):3153–3160, June 2021. URL: http://dx.doi.org/10.1002/ajmg.a.62399, doi:10.1002/ajmg.a.62399. This article has 3 citations.](https://doi.org/10.1002/ajmg.a.62399)